Results 241 to 250 of about 583,846 (360)
Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son +13 more
wiley +1 more source
A Novel In Vitro Potency Assay Demonstrating the Anti-Fibrotic Mechanism of Action of CDCs in Deramiocel. [PDF]
Li Y +6 more
europepmc +1 more source
Effect of acetazolamide on the anticonvulsant potency of several antiepileptic drugs in mice.
Juichi Sato +4 more
openalex +2 more sources
Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis
Theerut Luangmonkong +8 more
semanticscholar +1 more source
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad +12 more
wiley +1 more source
Structural insights into endogenous agonist selectivity of aminergic receptors from the octopamine β<sub>2</sub> receptor. [PDF]
Hori T +5 more
europepmc +1 more source
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués +3 more
wiley +1 more source
Structural Rationalization of IPMK Inhibitor Potency. [PDF]
Wang H, Shears SB, Blind RD.
europepmc +1 more source
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat +18 more
wiley +1 more source

